Rani Therapeutics Holdings Inc.
Last updated September 27, 2026
Organization details
- Legal name
- Rani Therapeutics Holdings Inc.
- Ownership
- Public
- Status
- Active
- SIC code
- 2834 — Pharmaceutical Preparations
- Jurisdiction of incorporation
- California
- Headquarters city
- SAN Jose
- Headquarters state / province
- California
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- RANI
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001856725
Board of directors
-
Abraham Bassan · DirectorSince 2025
-
Andrew Farquharson · DirectorSince 2023
-
Dennis A. Ausiello · DirectorSince 2023
-
Jean Luc Butel · DirectorSince 2023
-
Laureen Debuono · DirectorSince 2023
-
Lisa Ann Rometty · DirectorSince 2023
-
Maulik Nanavaty · DirectorSince 2023
-
Michelle Gilson · DirectorSince 2026
-
Mir A. Imran · DirectorSince 2023
-
Talat Imran · Director · Chief Executive OfficerSince 2023
-
Vasudev Jaiprakash Bailey · DirectorSince 2025
Chief executives
Talat Imran
· Chief Executive Officer
Dates unknown
Director election results
Annual meeting of May 28, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
91.3%
-
98.5%
-
99.6%
-
99.7%
-
99.8%
-
99.8%
-
99.8%
Board connections
3 of this board's directors also sit on 5 other boards.
- via Dennis A. Ausiello
- via Abraham Bassan
- via Abraham Bassan
- via Dennis A. Ausiello
- via Jean Luc Butel
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $1,320,867
- 3 purchases by 2 insiders
- Sold, last 12 months
- $15,714,731
- 3 sales by 2 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jul 21, 2026 | Mir A. Imran Director, 10% owner | Open-market purchase | +36,000 | $0.69 | $24,840 |
| Jul 17, 2026 | Talat Imran Director, Officer (Chief Executive Officer) | Open-market purchase | +35,000 | $0.72 | $25,193 |
| Jun 27, 2026 | Javadi Alireza Officer (Chief Technical Officer) | Shares withheld for tax | −309 | $0.74 | $229 |
| Jun 27, 2026 | Talat Imran Director, Officer (Chief Executive Officer) | Shares withheld for tax | −7,927 | $0.74 | $5,866 |
| Mar 27, 2026 | Javadi Alireza Officer (Chief Technical Officer) | Open-market sale | −386 | $0.78 | $301 |
| Mar 27, 2026 | Talat Imran Director, Officer (Chief Executive Officer) | Shares withheld for tax | −9,099 | $0.81 | $7,370 |
| Mar 22, 2026 | Talat Imran Director, Officer (Chief Executive Officer) | Shares withheld for tax | −8,916 | $1.13 | $10,075 |
| Dec 27, 2025 | Talat Imran Director, Officer (Chief Executive Officer) | Shares withheld for tax | −7,906 | $1.40 | $11,068 |
| Oct 23, 2025 | Mir A. Imran Director, 10% owner | Open-market purchase | +2,083,334 | $0.61 | $1,270,834 |
| Oct 21, 2025 | South Cone Investments Limited Partnership 10% owner | Open-market sale | −4,000,000 | $2.77 | $11,080,000 |
| Oct 20, 2025 | South Cone Investments Limited Partnership 10% owner | Open-market sale | −1,923,000 | $2.41 | $4,634,430 |
| Sep 27, 2025 | Talat Imran Director, Officer (Chief Executive Officer) | Shares withheld for tax | −9,077 | $0.48 | $4,357 |
| Jun 27, 2025 | Talat Imran Director, Officer (Chief Executive Officer) | Shares withheld for tax | −9,076 | $0.55 | $4,992 |
| Dec 27, 2024 | Talat Imran Director, Officer (Chief Executive Officer) | Open-market sale | −8,014 | $1.41 | $11,300 |
| Dec 13, 2024 | McKinley Kate Officer (Chief Business Officer) | Open-market purchase | +17,960 | $1.67 | $29,993 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.